Evidence map›Paper›PMID 39695883›Full record

ArticleStem cell research & therapy2024

An hiPSC-CM approach for electrophysiological phenotyping of a patient-specific case of short-coupled TdP.

Willem B van Ham, Esmeralda E M Meijboom, Merel L Ligtermoet, Jantine Monshouwer-Kloots, Anneline S J M Te Riele, Folkert W Asselbergs, Eva van Rooij, Mimount Bourfiss, Toon A B van Veen

Abstract readCase Reports
In one paragraph

Article in Stem cell research & therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. RRAGD p.(Ser76Leu) Variant Causes Dysregulated Expression of Muscle Development and Cytoskeleton Genes in Cardiomyocytes.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Willem B van HamDepartment of Medical Physiology, University Medical Center Utrecht, Utrecht, The Netherlands. W.B.vanHam-6@umcutrecht.nl.ORCID 0000-0002-6621-148X
Esmeralda E M MeijboomDepartment of Medical Physiology, University Medical Center Utrecht, Utrecht, The Netherlands.ORCID 0000-0001-8917-1460
Merel L LigtermoetDepartment of Medical Physiology, University Medical Center Utrecht, Utrecht, The Netherlands.
Jantine Monshouwer-KlootsHubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW), University Medical Center Utrecht, Utrecht, The Netherlands.
Anneline S J M Te RieleDepartment of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands.ORCID 0000-0002-4694-4790
Folkert W AsselbergsDepartment of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands.ORCID 0000-0002-1692-8669
Eva van RooijHubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW), University Medical Center Utrecht, Utrecht, The Netherlands.ORCID 0000-0002-2026-9408
Mimount Bourfiss *Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands.ORCID 0000-0001-5820-4610
Toon A B van Veen *Department of Medical Physiology, University Medical Center Utrecht, Utrecht, The Netherlands.ORCID 0000-0002-4775-5924

Funding

Dutch Cardiovascular Alliance CVON-PREDICT2 2018-30
6 · The paper itself

Abstract

introductionA healthy young woman, age 26 without prior cardiac complications, experienced an out-of-hospital cardiac arrest caused by ventricular fibrillation (VF), which coincided with a fever. Comprehensive diagnostics including echo, CMR, exercise testing, and genetic sequencing, did not identify any potential cause. This led to the diagnosis of idiopathic VF and installment of an implantable cardioverter defibrillator, which six months later appropriately intervened another VF episode under conditions comparable to the first event. A second diagnostic opinion concluded short-coupled Torsade de Pointes (scTdP), and the patient was started on a verapamil treatment.

methodsFrom this patient, human induced pluripotent stem cell cardiomyocyte (hiPSC-CM) lines were generated to study cellular electrophysiology. Without a known genetic pathogenic variation, no isogenic control line could be produced, therefore a healthy age- and sex-matched control hiPSC-CM line was used. Cellular electrophysiology was studied in these cardiomyocytes using calcium- and voltage sensitive fluorescent dyes and measurements were carried out at 37 °C and 39 °C, to mimic the condition of hyperthermia in the patient. mRNA expression of electrophysiologically relevant genes were analyzed to identify a potential underlying mechanism.

resultsCalcium transients measured in patient lines at a physiological temperature indicated the occurrence of early after transients (EATs). Strikingly, at 39 °C the incidence of EATs further increased. Membrane potential data from the patient also revealed shorter action potentials that, combined with the EATs, indicate the premature release of calcium during diastole, which could be responsible for the extrasystoles in the patient. Gene expression profiles were mainly downregulated in the patient but could not clearly aid in unraveling a mechanism behind the occurrence of EATs. Pharmacological screening was performed to evaluate the treatment regimen and to determine a mechanism of action of the EATs. While verapamil, dantrolene, and flecainide did not decrease the incidence of EATs, calcium handling parameters were affected indicating functionality of the drugs.

conclusionThis patient-specific case of electrophysiological phenotyping resulted in a hypothesis of the possible mechanism behind the scTdP arrhythmias, but also accentuates the applicability of patient-specific hiPSC-CM disease modeling and phenotyping.

Indexed as

Induced Pluripotent Stem CellsMyocytes, CardiacAdultCalciumFemaleHumansPhenotypeTorsades de PointesVentricular FibrillationCalciumCalcium handling dysfunctionhiPSC-CMPatient-specificPhenotypingShort-coupled Torsade de Pointes

Identifiers

PMID39695883
PMCPMC11656816

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.